Massachusetts resident Vicky Titcomb, 72, was diagnosed with pancreatic cancer in March 2025 following a routine heart scan at Mass General Brigham. The Cape Cod bookstore owner, who had previously undergone treatment for breast cancer in 2012, was also diagnosed with stage 1 breast cancer and a benign ovarian mass during the same period.
According to the American Association for Cancer Research 2026 Cancer Progress Report, pancreatic cancer remains one of the most lethal forms of the disease, with an overall five-year survival rate of 13%. The organization noted that while survival rates for most cancers have risen, statistics for pancreatic cancer have shown little improvement despite new treatment options.
Medical specialists at Mass General Brigham established a treatment plan for Titcomb, beginning with eight doses of chemotherapy over four months and three weeks of radiation. Surgical oncologist Dr. Thomas Clancy reported that the treatment successfully reduced the size of the pancreatic tumor, making Titcomb eligible for a robotic Whipple procedure. This complex surgery, which involves removing the head of the pancreas, the gallbladder, the bile duct, and part of the small intestine, is an option for approximately 20% of pancreatic cancer patients.
Titcomb underwent surgery for her breast cancer on November 4, followed by the robotic Whipple procedure just over two weeks later. After recovering from the operation and completing an additional two months of chemotherapy, Dr. Clancy informed Titcomb in March 2026 that there was no evidence of cancer. She is currently monitored with medical scans every three months.
The impact for patients involves a high-intensity clinical schedule. Titcomb’s treatment spanned approximately one year, including 10 total months of chemotherapy and three weeks of radiation. Patients undergoing such protocols notice significant changes in their daily lives, including the logistical need for family support to manage business or personal responsibilities. A robotic Whipple procedure specifically offers the possibility of smaller incisions and faster recovery times compared to traditional open surgery.
This case highlights the importance of incidental findings in routine medical imaging. As screening technologies for other conditions like heart disease become more frequent, the likelihood of detecting asymptomatic abdominal abnormalities increases. Titcomb now works with the Pancreatic Cancer Action Network and the American Cancer Society to advocate for research and legislative support. She will continue to undergo diagnostic imaging every 90 days to monitor for recurrence.